Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Non Operating Income: 2009-2024

Historic Non Operating Income for Cytokinetics (CYTK) over the last 16 years, with Dec 2024 value amounting to $51.5 million.

  • Cytokinetics' Non Operating Income fell 39.91% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.0 million, marking a year-over-year increase of 17.82%. This contributed to the annual value of $51.5 million for FY2024, which is 86.52% up from last year.
  • Cytokinetics' Non Operating Income amounted to $51.5 million in FY2024, which was up 86.52% from $27.6 million recorded in FY2023.
  • Cytokinetics' 5-year Non Operating Income high stood at $51.5 million for FY2024, and its period low was $331,000 during FY2021.
  • In the last 3 years, Cytokinetics' Non Operating Income had a median value of $27.6 million in 2023 and averaged $30.2 million.
  • As far as peak fluctuations go, Cytokinetics' Non Operating Income slumped by 93.79% in 2021, and later skyrocketed by 3,326.59% in 2022.
  • Over the past 5 years, Cytokinetics' Non Operating Income (Yearly) stood at $5.3 million in 2020, then tumbled by 93.79% to $331,000 in 2021, then surged by 3,326.59% to $11.3 million in 2022, then surged by 143.60% to $27.6 million in 2023, then spiked by 86.52% to $51.5 million in 2024.